Mechanism of cross‐resistance to cisplatin in a mitomycin C‐resistant human bladder cancer cell line

International journal of cancer

How resistance to mitomycin C may cause resistance to cisplatin in human bladder cancer cells

AI simplified

Page updated

Abstract

The J82/MMC cell line displayed 2- to 3-fold cross-resistance to cisplatin compared to parental J82/WT cells.

  • Cross-resistance to cisplatin in J82/MMC cells is independent of reduced platinum accumulation.
  • J82/MMC cells show approximately a 1.5-fold resistance to cadmium chloride, indicating increased metallothionein content.
  • Northern blot analysis revealed a 2.7-fold increase in MT-IIA mRNA levels in J82/MMC cells compared to J82/WT.
  • Elevated glutathione transferase activity in J82/MMC cells is linked to over-expression of pi-type GST protein.
  • GSH depletion enhances cisplatin cytotoxicity more significantly in J82/MMC cells (about 2.1-fold) compared to J82/WT (about 1.6-fold).

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free